simpleDigital Health Ecosystem MappingDigital HealthFunding

North America Digital Health Innovation 2023 Year End Report

Galen Growth’s North America Digital Health Innovation 2023 Year End Report is a fundamental resource, providing in-depth analysis for industry leaders, investors, and innovators. We focus our analysis on ecosystem key trends, through the lens of ecosystem growth, most active partners, regulatory approvals, key categories, therapeutic areas, venture funding, and more.

North America Digital Health Innovation 2023 Year End Report

Galen Growth is pleased to share with you our 2023 Year-End Report on Digital Health Key Trends in North America. This report looks across the Digital Health startup ecosystem to reflect on the 2023 trends and move the industry forward into 2024. Our analysis focuses on private ventures and includes most active partners, regulatory approvals and venture funding strength, among others. HealthTech Alpha, a Galen Growth proprietary solution, and the world’s leading Digital Health private market data, intel and insights platform powers this report!

Highlights from the 2023 North America Digital Health Innovation Report

Despite global funding declines, North American Digital Health ventures navigate challenges to secure funding

  • North America saw a 29% decrease YoY in Digital Health venture funding in 2023, while Europe experienced a 42% decrease.
  • At the end of 2023, 43% of growth-stage Digital Health ventures in both North America and Europe had secured funding within the past 18 months.

Health Systems emerge as key partners, strengthening the North American Digital Health ecosystem through collaboration.

  • Health Systems (including private clinics and hospitals) took the largest share of new partnerships announced with North American-founded Digital Health ventures in 2023.
  • The number of partnerships between North American Digital Health ventures and Health Systems increased by 1.2x in 2023 compared to 2022.

AI Adoptions Gains Traction, Research Solutions Cluster Outperforms

  • 2% of North American Digital Health ventures leveraged Generative AI (GenAI) technologies in 2023, while an additional 41% used other forms of AI.
  • 19% of North American Digital Health ventures leveraging AI were in the Health Management Solutions cluster.
  • Research Solutions emerges as the top-funded Digital Health cluster, fuelled by AI. In 2023, it attracted 22% of the total regional funding.

Ventures and Companies Covered in the Report

The “2023 North America Digital Health Innovation Year End Report” includes data on the following companies:
Ayble Health, CipherHealth, Alto Pharmacy, Sesame, Headway, Phenomic AI, Monogram Health, Aledade, HeartFlow, Gravie, Cortica, Tonal, Generate Biomedicines, Orbital Therapeutics, Strive Health, Tendo Systems, Harbinger Health, Employer Direct Healthcare, RapidAI, Cognito Therapeutics, Zipline, Haystack Oncology, Dialogue, Cloudbreak Health, Revela, Valence Discovery, Recursion, Neumora Therapeutics, Turnstone Biologics, FORME, Bullfrog AI, Fauna Bio, Arbor Biotechnologies, NourishedRx, Previta, Mayo Clinic , Google Cloud, Cost Plus Drugs, Walmart, Evernorth, Oddity, Quest Diagnostics, Sun Life, Lilly, Ginkgo Bioworks, Blue Plus, Cleveland Clinic, Astellas Pharma, Boehringer Ingelheim, Memorial Hermann Health System, Cigna Ventures, Humana, MAPS Capital, NVentures, Pictet Group, ARCH Venture Partners, GTCR

Delve into the Digital Health Innovation 2023 Year End Reports for Europe and Asia Pacific

Get the report

Use your company email address. Personal and disposable email services are not accepted.